Catalog No.
RHF53501
Species reactivity
Human, Mouse, Monkey
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:50-1:200, IP: 1:20, WB: 1:500-1:1000
Target
RAN, Androgen receptor-associated protein 24, GTPase Ran, Ras-related nuclear protein, ARA24, GTP-binding nuclear protein Ran, Ras-like protein TC4
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P62826
Applications
IF, IP, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R2A47
Immunotherapy in breast cancer: current landscape and emerging trends., PMID:40405250
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial., PMID:40384614
Dual targeting of ENPP3 and SIRPα with a bispecific antibody enhances macrophage-mediated immunity in renal cell carcinoma., PMID:40349459
Wearable Photonic Device for Multiple Biomarker Sampling and Detection without Blood Draws., PMID:40326959
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial., PMID:40255182
Performance characteristics of three Brucella canis serological assays in the United States., PMID:40235569
A "CPApoptosis" nano-actuator switches immune-off solid tumors to immune-on for fueling T-cell- based immunotherapy., PMID:40213664
Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity., PMID:40209501
Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant Melanoma., PMID:40204067
A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors., PMID:40158720
Magnetic Nanoparticles Stabilized by Phosphorylcholine-Containing Polymer for Label-Free C-Reactive Protein Detection., PMID:40124022
Rheology of CHO Cell Suspensions and Its Effects on High-Density Cultivation Process and Bioreactor Design., PMID:40100242
Macrophage-targeting combination therapy enhances T-DXd-induced tumor regression., PMID:40088875
Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies., PMID:40056201
[Two cases of type 1 autoimmune pancreatitis diagnosed by duodenal papilla biopsy]., PMID:40050095
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response., PMID:40035515
Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity., PMID:39989295
Long-term predictions of COVID-19 waves in China based on an improved SEIRS-Q model of antibody failure., PMID:39977464
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT., PMID:39949023
CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk., PMID:39937857
[Immunorelated Stevens-Johnson syndrome/toxic epidermolysis caused by programmed death receptor 1 inhibitors: a case report]., PMID:39914838
Long-Term Lipid Lowering With Evolocumab in Older Individuals., PMID:39909681
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer., PMID:39879779
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial., PMID:39874903
Randomized comparison of the combined Sirolimus eluting and endothelial progenitor cell combo Stent vs. biolimus eluting absorbable polymer coated biomatrix alpha stent in patients undergoing percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for randomized trials with clinical outcome (SORT OUT) XI trial., PMID:39870125
L1CAM+ extracellular vesicles derived from the serum of adolescents with major depressive disorder induce depression-like phenotypes in adolescent mice., PMID:39842672
RNF128 deficiency in macrophages promotes colonic inflammation by suppressing the autophagic degradation of S100A8., PMID:39809743
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period., PMID:39762664
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial., PMID:39739622
Re-evaluation of the relationship between PrPc expression and patient prognosis in primary esophageal squamous cell carcinoma and primary hepatocellular carcinoma., PMID:39732816
A study of autoimmune thyroid disease in pregnant women and its effect on fetal and maternal outcome., PMID:39722948
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab., PMID:39718423
OmpH is Involved in the Decrease of Acinetobacter baumannii Biofilm by the Antimicrobial Peptide Cec4., PMID:39664965
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series., PMID:39660186
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study., PMID:39652286
Prevalence of immunity to hepatitis B in NCAA athletes., PMID:39601800
Protective Impact of Influenza Vaccination on Healthcare Workers., PMID:39591140
The consequences of SARS-CoV-2 within-host persistence., PMID:39587352
Immunogenicity and Safety of COVID-19 Vaccines in Patients with Lung Cancer: Results of a Systematic Review and Meta-Analysis., PMID:39557036
Assessment of Single-Cycle M-Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS-CoV-2 Immunogen Delivery., PMID:39526809
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial., PMID:39501485
Autocatalysis-Integrated Bioorthogonal (Poly)Catalyst-Linked Immunosorbent Assay for Living Cell Membrane Antigens., PMID:39468940
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)., PMID:39442013
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China., PMID:39426385
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis., PMID:39417358
Effects on molecular interactions of hollow gold nanoparticles and antibody for sensitizing P24 antigen determination., PMID:39315032
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis., PMID:39305187
Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters., PMID:39293542
Pichia pastoris composition expressed aerolysin mutant of Aeromonas veronii as an oral vaccine evaluated in zebrafish (Danio rerio)., PMID:39219683
Idiopathic Inflammatory Myopathies-Associated Interstitial Lung Disease in Adults., PMID:39219439
For research use only. Not for human or drug use.
